Best Practice & Research Clinical Haematology
Volume 19, Issue 2 , Pages 259-262 , June 2006

  • Jacob M. Rowe, MD

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +972 4 854 2541; fax: +972 4 854 2343

References 

  1. Kottaridis PD, Gale RE, Frew ME, et al. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood. 2001;98:1752–1759
  2. Dohner K, Tobis K, Ulrich R, et al. Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm. Journal of Clinical Oncology. 2002;20:3254–3261
  3. Barragan E, Cervera J, Bolufer P, et al. Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia. Haematologica. 2004;89:926–933
  4. Bullinger L, Dohner K, Bair E, et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. The New England Journal of Medicine. 2004;350:1605–1616

PII: S1521-6926(05)00123-4

doi: 10.1016/j.beha.2005.11.009

Best Practice & Research Clinical Haematology
Volume 19, Issue 2 , Pages 259-262 , June 2006

Article Tools

* Image Usage & Resolution